bioRxiv · 10.1101/2022.02.10.480003
CaSee: A lightning transfer-learning model directly used to discriminate cancer/normal cells from scRNA-seq
Abstract
Single-cell RNA sequencing (scRNA-seq) is one of the most efficient technologies for human tumor research. However, data analysis is still faced with some technical challenges, especially the difficulty in efficiently and accurately discriminate cancer/normal cells in the scRNA-seq expression matrix. In this study, we developed a cancer/normal cell discrimination pipeline called pan-cancer seeker (CaSee) devoted to scRNA-seq expression matrix, which is based on the traditional high-quality pan-cancer bulk sequencing data using transfer learning. It is compatible with mainstream sequencings technology platforms, 10x Genomics Chromium, Smart-seq2, and Microwell-seq. Here, CaSee pipeline exhibited excellent performance in the multicenter data evaluation of 11 retrospective cohorts and one independent dataset, with an average discrimination accuracy of 96.69%. In general, the development of a deep-learning based, pan-cancer cell discrimination model, CaSee, to distinguish cancer cells from normal cells will be compelling to researchers working in the genomics, cancer, and single-cell fields.
Source connections
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Sh, Y., Zhang, X., Guo, C., Shi, F., Jia, F., Hu, Z.. 2022-02-11. CaSee: A lightning transfer-learning model directly used to discriminate cancer/normal cells from scRNA-seq. https://doi.org/10.1101/2022.02.10.480003
Cite the original work for its findings. Save a collection to share your selection of sources.